ArticleBMC microbiology2026
The synergistic antimicrobial effect of tetrasodium EDTA and chlorhexidine against Enterobacterales isolates from hospital carriers.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHospital-acquired infections are a major concern in healthcare settings, often involving Gram-negative bacilli that affect both patients and healthcare personnel. This study aimed to assess the antimicrobial effects of chlorhexidine and EDTA, alone and in combination, on Gram-negative bacilli isolated from carriers, along with their antibiotic resistance profiles and biofilm-forming abilities.
methodsThis cross-sectional study collected 390 samples from hospital personnel, patients and environmental surfaces to investigate Gram-negative bacilli. Antibiotic susceptibility, biofilm formation, and the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of chlorhexidine, with and without EDTA, were also determined. PCR also was used to detect biocide resistance genes (qacE, qacEΔ1, CepA).
resultsA total of 120 Gram-negative bacilli were isolated and subsequently confirmed through biochemical tests. Klebsiella pneumoniae was the predominant bacterial species, accounting for 70% (n=84). Based on the present findings, 29 (24.1%) isolates were multidrug-resistant (MDR). ESBL and AmpC production were detected in 12.5% and 21% of isolates, respectively. Strong biofilm formation was observed in 58.3% of the samples. Chlorhexidine alone inhibited bacterial growth at a MIC₉₀ of 0.009%, with a bactericidal effect at 0.019%. When combined with EDTA, a synergistic effect was observed, reducing the MIC to 0.002% and the MBC to 0.004%, indicating enhanced antimicrobial activity (P ≤ 0.05).
conclusionsThese findings indicate a considerable prevalence of antibiotic-resistant and biofilm-producing Gram-negative bacilli among carriers. Furthermore, the increased activity observed with the combination of chlorhexidine and EDTA suggests that this approach may represent a potentially useful option for decontamination and infection control in healthcare settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.